Barclays’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-34
| Closed | – | – | 6945 |
|
|
2016
Q1 | $0 | Sell |
34
-39
| -53% | -$70 | ﹤0.01% | 6745 |
|
|
2015
Q4 | $0 | Sell |
73
-7,618
| -99% | -$22.6K | ﹤0.01% | 7120 |
|
|
2015
Q3 | $15K | Buy |
7,691
+6,087
| +379% | +$15.9K | ﹤0.01% | 5608 |
|
|
2015
Q2 | $5K | Sell |
1,604
-16,437
| -91% | -$56.3K | ﹤0.01% | 6519 |
|
|
2015
Q1 | $36K | Buy |
18,041
+2,374
| +15% | +$6.07K | ﹤0.01% | 5506 |
|
|
2014
Q4 | $32K | Sell |
15,667
-16,224
| -51% | -$71K | ﹤0.01% | 6036 |
|
|
2014
Q3 | $225K | Sell |
31,891
-2,149
| -6% | -$20.1K | ﹤0.01% | 4641 |
|
|
2014
Q2 | $375K | Sell |
34,040
-64,109
| -65% | -$684K | ﹤0.01% | 4250 |
|
|
2014
Q1 | $1.08M | Buy |
98,149
+62,619
| +176% | +$737K | ﹤0.01% | 3172 |
|
|
2013
Q4 | $356K | Buy |
35,530
+22,519
| +173% | +$222K | ﹤0.01% | 4425 |
|
|
2013
Q3 | $130K | Buy |
13,011
+749
| +6% | +$8.53K | ﹤0.01% | 5414 |
|
|
2013
Q2 | $144K | Buy |
+12,262
| New | +$122K | ﹤0.01% | 5484 |
|
Barclays's SZYM Position: Q2 2016 in Review
Barclays sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 34 shares.
Barclays first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $1.08M in Q1 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.
- Barclays reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
- Barclays sold 34 SOLAZYME INC COM STK (DE) shares in Q2 2016.
- Barclays first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
- Barclays's SOLAZYME INC COM STK (DE) position peaked at $1.08M in Q1 2014.
- 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.
Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.